Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXHS1800020 | 盐酸拉维达韦片 | ravidasvir hydrochloride | Tablet | Chemical Drugs(1) | New Drug Application | 2018-08-06 | 歌礼药业(浙江)有限公司 | Ascletis Pharmaceuticals Co Ltd | Certificate Issued | 2020-08-04 | view |
CXHS1800019 | 盐酸拉维达韦 | ravidasvir hydrochloride | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-08-06 | 歌礼药业(浙江)有限公司 | Ascletis Pharmaceuticals Co Ltd | In Review | 2018-08-02 | view |
CYHB2007761 | 盐酸拉维达韦片 | ravidasvir hydrochloride | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-10-15 | 歌礼生物科技(杭州)有限公司 | Ascletis Biological Technology(Hangzhou) Co Ltd | Certificate Issued | 2021-02-26 | view |